Clinical Significance of Subclinical Atherosclerosis in Retinal Vein Occlusion

Overview

Journal Sci Rep

Specialty Science

Date 2021 Jun 8

PMID 34099806

Citations 7

Authors

Minhyung Lyu

Yonggu Lee

Byung Sik Kim

Hyun-Jin Kim

Rimkyung Hong

Yong Un Shin

Heeyoon Cho

Jeong-Hun Shin

Affiliations

Soon will be listed here.

Abstract

Retinal vein occlusion (RVO) is associated with atherosclerotic cardiovascular risk factors; however, its association with the specific markers of subclinical atherosclerosis has not yet been established. To investigate this association, we compared 70 patients with RVO to 70 age- and sex-matched patients without RVO. Low-density lipoprotein cholesterol (LDL-C) levels and brachial-ankle pulse wave velocity (baPWV) were significantly higher in the RVO group than in the control group. Carotid plaques (54.3% vs. 28.6%, p = 0.004) were more frequent in the RVO group. Multivariate logistic regression analysis showed that the presence of carotid plaques (odds ratio [OR]: 3.15, 95% confidence interval [CI] 1.38-7.16, p = 0.006), as well as smoking, LDL-C level, and baPWV were associated with RVO. Additionally, a multinomial logistic regression model showed that the presence of carotid plaques (OR: 3.94, 95% CI 1.65-9.41, p = 0.002) and LDL-C level were associated with branch RVO, whereas smoking and baPWV were associated with central RVO. In conclusion, RVO was associated with subclinical atherosclerosis markers, including carotid plaques and baPWV. These results support the hypothesis that atherosclerosis contributes to the etiology of RVO and suggest the evaluation of subclinical atherosclerosis in patients with RVO.

Citing Articles

Association of arterial stiffness and eye disease: a systematic review and meta-analysis.

Beros A, Sluyter J, Scragg R BMJ Open Ophthalmol. 2025; 10(1).

PMID: 39855645 PMC: 11759874. DOI: 10.1136/bmjophth-2024-001980.

Endothelial Glycocalyx Damage and Arterial Thickness in Patients with Retinal Vein Occlusion (RVO).

Korakas E, Pavlidis G, Lampsas S, Agapitou C, Risi-Koziona A, Kountouri A J Clin Med. 2025; 14(1.

PMID: 39797194 PMC: 11721581. DOI: 10.3390/jcm14010111.

Vitamin D deficiency in patients with retinal vein occlusion: a systematic review and meta-analysis.

Daneshvar K, Akhlaghi M, Iranpour S, Irajpour M, Pourazizi M Int J Retina Vitreous. 2024; 10(1):52.

PMID: 39068491 PMC: 11282712. DOI: 10.1186/s40942-024-00571-3.

Clinical effects of atorvastatin combined with conbercept in the treatment of patients with macular edema secondary to retinal vein occlusion and carotid plaque: study protocol for a prospective randomized controlled trial.

Yao B, Wang B, Yang J, Geng Y, Yu H, Liu Y Trials. 2024; 25(1):244.

PMID: 38589960 PMC: 11000300. DOI: 10.1186/s13063-024-08082-0.

Maximum carotid intima-media thickness and NT-pro BNP in association with retinal vein occlusion.

Onoe H, Tanaka K, Tsuchiya N, Miyata K, Kitaoka M, Nakayama M PLoS One. 2023; 18(12):e0291456.

PMID: 38096214 PMC: 10721079. DOI: 10.1371/journal.pone.0291456.

References

Rath E, Frank R, Shin D, Kim C . Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 1992; 99(4):509-14. DOI: 10.1016/s0161-6420(92)31940-2. View

Kim H, Im M, Seo J, Chung W, Kim S, Kim M . The association between arterial stiffness and left ventricular filling pressure in an apparently healthy Korean population. Cardiovasc Ultrasound. 2013; 11(1):2. PMC: 3554540. DOI: 10.1186/1476-7120-11-2. View

Martinez F, Furio E, Fabia M, Perez A, Gonzalez-Albert V, Rojo-Martinez G . Risk factors associated with retinal vein occlusion. Int J Clin Pract. 2014; 68(7):871-81. DOI: 10.1111/ijcp.12390. View

Kang M, Balaratnasingam C, Yu P, Morgan W, McAllister I, Cringle S . Alterations to vascular endothelium in the optic nerve head in patients with vascular comorbidities. Exp Eye Res. 2013; 111:50-60. DOI: 10.1016/j.exer.2013.03.005. View

Scott I, Campochiaro P, Newman N, Biousse V . Retinal vascular occlusions. Lancet. 2020; 396(10266):1927-1940. PMC: 9546635. DOI: 10.1016/S0140-6736(20)31559-2. View

Zhou J, Xu L, Wang S, Wang Y, You Q, Tu Y . The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study. Ophthalmology. 2013; 120(4):803-8. DOI: 10.1016/j.ophtha.2012.09.033. View

OMahoney P, Wong D, Ray J . Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008; 126(5):692-9. DOI: 10.1001/archopht.126.5.692. View

Inaba Y, Chen J, Bergmann S . Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis. 2011; 220(1):128-33. DOI: 10.1016/j.atherosclerosis.2011.06.044. View

Jaulim A, Ahmed B, Khanam T, Chatziralli I . Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina. 2013; 33(5):901-10. DOI: 10.1097/IAE.0b013e3182870c15. View

10.

Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang J . The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis. Curr Atheroscler Rep. 2016; 18(12):82. DOI: 10.1007/s11883-016-0632-z. View

11.

Hayreh S, Zimmerman B, McCarthy M, Podhajsky P . Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001; 131(1):61-77. DOI: 10.1016/s0002-9394(00)00709-1. View

12.

Nakazato K, Watanabe H, Kawana K, Hiraoka T, Kiuchi T, Oshika T . Evaluation of arterial stiffness in patients with branch retinal vein occlusion. Ophthalmologica. 2005; 219(6):334-7. DOI: 10.1159/000088374. View

13.

Andrus B, Lacaille D . 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014; 63(25 Pt A):2886. DOI: 10.1016/j.jacc.2014.02.606. View

14.

Klein R, Moss S, Meuer S, Klein B . The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008; 126(4):513-8. DOI: 10.1001/archopht.126.4.513. View

15.

Boren J, Chapman M, Krauss R, Packard C, Bentzon J, Binder C . Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313-2330. PMC: 7308544. DOI: 10.1093/eurheartj/ehz962. View

16.

Cheung N, Klein R, Wang J, Cotch M, Islam A, Klein B . Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci. 2008; 49(10):4297-302. PMC: 2584770. DOI: 10.1167/iovs.08-1826. View

17.

Cugati S, Wang J, Knudtson M, Rochtchina E, Klein R, Klein B . Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology. 2006; 114(3):520-4. DOI: 10.1016/j.ophtha.2006.06.061. View

18.

Matsushima C, Wakabayashi Y, Iwamoto T, Yamauchi Y, Usui M, Iwasaki T . Relationship between retinal vein occlusion and carotid artery lesions. Retina. 2007; 27(8):1038-43. DOI: 10.1097/IAE.0b013e31806196bc. View

19.

Zhao J, Sastry S, Sperduto R, Chew E, Remaley N . Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology. 1993; 100(3):423-8. DOI: 10.1016/s0161-6420(93)31633-7. View

20.

Wong T, Larsen E, Klein R, Mitchell P, Couper D, Klein B . Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology. 2005; 112(4):540-7. DOI: 10.1016/j.ophtha.2004.10.039. View